GLP-1 Drugs Like Ozempic and Kidney Stones: Why Dehydration, Not the Drug, Is the Real Link
March 25, 2026 — As GLP-1 medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) become mainstream for diabetes and weight management, a practical question has reached urology clinics: do these drugs raise kidney stone risk? A UAB Heersink School of Medicine review published in March 2026 gives a nuanced answer — and it is mostly reassuring.
What the Evidence Actually Shows
Kyle Wood, M.D., a urologist at UAB, stated that clinical studies have not demonstrated a clear increase in kidney stone formation among GLP-1 users. He pointed to one large observational study from the U.S. Department of Veterans Affairs that suggested a possible association, but noted that follow-up metabolic evaluations — including 24-hour urine comparisons — did not support a direct causal link. "GLP-1 medications do not currently appear to directly increase kidney stone risk," Wood said. He added that multiple publications evaluating 24-hour urines of GLP-1 users versus non-users show overall no increased risks.
This aligns with other clinical commentary. WakeMed's kidney stone center and multiple urology practices note the same pattern: the drug itself is not the crystal-forming agent. The real mechanism is behavioral — and therefore controllable.
The Dehydration Mechanism
GLP-1 drugs work partly by slowing gastric emptying and blunting appetite. In the first weeks — and after each dose increase — they commonly cause nausea, vomiting, and diarrhea. Many patients simply stop feeling like drinking. When fluid intake drops, urine concentrates, and concentrated urine is the physical state in which calcium oxalate and uric acid crystals fall out of solution. One urology practice described a patient who, after a tirzepatide dose step-up, presented with renal colic and apple-juice-colored urine — having barely kept fluids down for days because nausea made drinking unpleasant.
As one urologist put it bluntly: the drug did not make the stone — the empty water bottle did. This is the same mechanism behind stones in anyone who chronically under-hydrates. Getting fluid intake right does more to prevent stones than any single food rule.
The AUA Number That Matters
The American Urological Association names a urine output of about 2.5 liters per day as the single most effective stone-prevention step, estimating it can cut recurrence by more than half. Reaching 2.5 L of urine typically requires roughly 3 L (about 100 fl oz) of fluid intake, adjusted for climate and sweat. On GLP-1 drugs, nausea makes large gulps unpleasant — so the practical fix is small, frequent sips and keeping a bottle within reach on dose-increase days.
High-Oxalate Foods to Watch While on GLP-1s
If you are prone to calcium oxalate stones, hydration is priority one — but limiting high-oxalate foods during a nausea-prone window is a useful second layer. Below are lab-measured values for common trigger foods.
| Food (serving) | Oxalate | Verdict |
|---|---|---|
| Rhubarb, raw (1 cup diced) | 1293 mg | Avoid |
| Spinach, boiled (1/2 cup) | 493 mg | Avoid |
| Almonds (1/4 cup) | 107 mg | Avoid |
| Dark chocolate (1 oz) | 65 mg | Caution |
| Apple, fresh (1 medium) | 2 mg | Safe |
| Milk, cow (1 cup) | 1 mg | Safe |
All oxalate values: Harvard T.H. Chan School of Public Health Oxalate Database (2024), lab-measured via ion chromatography. Verdicts: Safe <25 mg/serving, Caution 25–99 mg, Avoid ≥100 mg.
Do Not Cut Calcium — Pair It
A common mistake is eliminating dairy to "avoid stones." Dietary calcium from food (around 1,000–1,200 mg/day) actually lowers stone risk by binding oxalate in the gut before it reaches the kidneys. A daily glass of lemon water or low-sugar citrus adds citrate, a natural crystal inhibitor. The goal is balanced calcium plus adequate fluid, not elimination. Cutting calcium can backfire by increasing oxalate absorption.
Who Should Be Extra Careful
Clinicians identify higher-risk GLP-1 users as those with: a prior stone history, gastrointestinal intolerance, older age, rapid dose escalation, or use of diuretics or other fluid-losing medications. A 2026 remote study at the University of Michigan is even testing whether a smart water bottle plus app reminders can improve hydration in GLP-1 users with a stone history — a sign the field is taking the dehydration link seriously without overstating the drug risk. The study's premise is that staying well hydrated is known to help, but how best to support these patients in building the habit is not yet clear.
Fact vs. Inference
Studies indicate GLP-1 drugs do not directly cause stones; the dehydration they can trigger is the documented pathway. It would be an overstatement to claim these medications "cause kidney stones," just as it would be wrong to say they are risk-free for someone who stops drinking. The balanced view — benefits of metabolic improvement generally outweigh stone risk, provided hydration is protected — is what current urology guidance supports.
Frequently Asked Questions
Do Ozempic or Wegovy cause kidney stones directly?
Current evidence does not support a direct causal link. Large reviews and 24-hour urine studies show no clear increase in stone formation. The concern is indirect: nausea-related dehydration concentrates urine.
How much water should I drink on a GLP-1 drug?
Aim for about 2.5 liters of urine per day, which usually means close to 3 liters of fluid. Small, frequent sips are easier than large amounts when nauseated.
Should I stop my GLP-1 medication because of stone risk?
Generally no. Clinicians note the metabolic benefits often outweigh stone risk, and a prior stone is not a reason to avoid the drug — provided you protect hydration and follow your care team's plan.
Why does nausea raise stone risk more than the drug itself?
Nausea and vomiting reduce fluid intake and increase losses. Low urine volume is the main determinant of stone risk, so dehydration — not the molecule — is the trigger.
Quick Takeaways
- GLP-1 drugs do not directly cause stones; dehydration from nausea is the documented pathway.
- Aim for ~2.5 L urine/day (about 3 L fluid), using small frequent sips on nausea days.
- Limit highest-oxalate foods (rhubarb, spinach, almonds) during prone windows.
- Keep dietary calcium — don't cut dairy; pair it with oxalate to bind in the gut.
- A stone history is not a reason to avoid the drug, but protect hydration vigilantly.
Bottom line: If you take a GLP-1 medication and have a stone history, the most important action is not avoiding the drug — it is protecting your fluid intake through every nausea-prone window, keeping urine pale, and limiting the highest-oxalate foods.